Publicacións en colaboración con investigadores/as de Hospital Clinic Barcelona (19)

2024

  1. Heterologous mRNA/MVA delivering trimeric-RBD as effective vaccination regimen against SARS-CoV-2: COVARNA Consortium

    Emerging Microbes and Infections, Vol. 13, Núm. 1

2022

  1. Microbiome in Immune-Mediated Uveitis

    International Journal of Molecular Sciences, Vol. 23, Núm. 13

  2. PET study of intravitreal adalimumab pharmacokinetics in a uveitis rat model

    International Journal of Pharmaceutics, Vol. 627

  3. Patient Experience Evaluation of the CMO-Based Pharmaceutical Care Model vs Usual Care in People Living with HIV

    Journal of Multidisciplinary Healthcare, Vol. 15, pp. 2991-3003

  4. The economic burden of pulmonary arterial hypertension in Spain

    BMC Pulmonary Medicine, Vol. 22, Núm. 1

2021

  1. Anti-inflammatory effect of tacrolimus/hydroxypropyl-β-cyclodextrin eye drops in an endotoxin-induced uveitis model

    Pharmaceutics, Vol. 13, Núm. 10

  2. Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort Study

    Infectious Diseases and Therapy, Vol. 10, Núm. 1, pp. 347-362

  3. Improved diagnosis of gastrointestinal infections using a semi-automated multiplex real-time PCR for detection of enteropathogens

    Journal of Medical Microbiology, Vol. 70, Núm. 9

  4. Neurotoxicity associated with acyclovir and valacyclovir: A systematic review of cases

    Journal of Clinical Pharmacy and Therapeutics, Vol. 46, Núm. 4, pp. 918-926

2020

  1. Author Correction: Identification and characterization of Cardiac Glycosides as senolytic compounds (Nature Communications, (2019), 10, 1, (4731), 10.1038/s41467-019-12888-x)

    Nature Communications

2018

  1. Effect of a Structured Pharmaceutical Care Intervention Versus Usual Care on Cardiovascular Risk in HIV Patients on Antiretroviral Therapy: INFAMERICA Study

    Annals of Pharmacotherapy, Vol. 52, Núm. 11, pp. 1098-1108

2017

  1. Evaluation of a multiplex panel for the diagnosis of acute infectious diarrhea in immunocompromised hematologic patients

    PLoS ONE, Vol. 12, Núm. 11

2016

  1. Consumption of systemic antifungal agents among acute care hospitals in Catalonia (Spain), 2008-2013

    Expert Review of Anti-Infective Therapy, Vol. 14, Núm. 1, pp. 137-144

2014

  1. Aetiology of traveller's diarrhoea: Evaluation of a multiplex PCR tool to detect different enteropathogens

    Clinical Microbiology and Infection, Vol. 20, Núm. 10, pp. O753-O759

  2. Análisis coste-efectividad de aflibercept en combinación con FOLFIRI en el tratamiento de pacientes con cáncer colorrectal metastásico

    Farmacia Hospitalaria, Vol. 38, Núm. 4, pp. 317-327

  3. Extended spectrum β-lactamase-producing escherichia coli faecal carriage in Spanish travellers returning from tropical and subtropical countries

    Clinical Microbiology and Infection, Vol. 20, Núm. 10, pp. O636-O639

  4. Situación actual de la estructura, procesos y resultados de la atención farmacéutica al paciente VIH en España. Proyecto origen

    Farmacia Hospitalaria, Vol. 38, Núm. 2, pp. 89-99

2012

  1. The undiagnosed cases of Clostridium difficile infection in a whole nation: Where is the problem?

    Clinical Microbiology and Infection, Vol. 18, Núm. 7

2004

  1. Length of stay and antipsychotic treatment costs of patients with acute psychosis admitted to hospital in Spain - Description and associated factors - The Psychosp study

    Social Psychiatry and Psychiatric Epidemiology, Vol. 39, Núm. 7, pp. 507-513